Brent Ragans named President of Ferring US

Brent Ragans named President of Ferring US
June 1, 2020 rupalivakils
PRESS RELEASE 2020

Brent Ragans named President of Ferring US

  • Ragans is now responsible for Ferring US commercial, manufacturing and development operations
  • Ragans joined Ferring, a world leader in reproductive medicine, in 2012 and was named US Chief Commercial Officer in 2016

Parsippany, NJ – June 1, 2020 – Ferring Pharmaceuticals (US) announced today that Brent Ragans has been appointed as President. In this role Mr. Ragans oversees the commercial, manufacturing and development operations of the global Ferring Pharmaceuticals Group in the United States.

Ferring is entering a new phase in which it will expand its leadership in Reproductive Medicine and Maternal Health, Orthopaedics and Gastroenterology,” said Mr. Ragans. “Among the highlights, we look forward to seeking regulatory approval for what may become the world’s first approved microbiome-based therapy.”  

Originally from Jacksonville, Florida, Brent Ragans has more than 30 years’ experience in the pharmaceutical business. He joined Ferring Pharmaceuticals (US) as vice president of commercial operations in 2012 and was named chief commercial officer in 2016. Prior to Ferring, he led North American consumer healthcare strategy and corporate development for Sanofi. Earlier during 12 years at Sanofi, he managed major business units, including general therapeutics, specialty markets, and cardiovascular, and led teams of more than 2500 representatives.

As the President of Ferring US, Mr. Ragans reports to Aaron Graff, Global Chief Commercial Officer, Member of the Executive Committee and Executive Chairman of Ferring Holding Inc. (US). Mr. Ragans succeeds Paul Navarre, who is leaving the company.

“Brent has been one of the key architects of our US business since joining Ferring eight years ago,” said Aaron Graff, Global Chief Commercial Officer, Member of the Executive Committee and Executive Chairman of Ferring Holding Inc. (US). “His track record of success, broad background and deep knowledge of Ferring positions him well to lead the company into its next successful chapter.”

 

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. In the United States, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopaedics. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com

 

 

# # #

For more information, please contact

Patrick Gorman                                                             
Director, External Communications
(862) 286-5035 (direct)

(973) 722-6335 (mobile)
patrick.gorman@ferring.com

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK